ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PASG Passage Bio Inc

1.27
0.05 (4.10%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Passage Bio Inc PASG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 4.10% 1.27 08:37:33
Open Price Low Price High Price Close Price Previous Close
1.22 1.22 1.33 1.32 1.22
more quote information »

Recent News

Date Time Source Heading
22/4/202421:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
05/3/202423:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
05/3/202409:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202408:09EDGAR2Form S-3 - Registration statement under Securities Act of..
04/3/202423:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202423:02EDGAR2Form 8-K - Current report
04/3/202423:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
01/3/202408:06EDGAR2Form 8-K - Current report
27/2/202423:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
15/2/202401:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:05EDGAR2Form 8-K - Current report
04/1/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202308:15EDGAR2Form 8-K - Current report
20/12/202323:05EDGAR2Form 8-K - Current report
20/12/202323:00GLOBEPassage Bio Announces Promising Initial Data From Phase 1/2..
18/11/202308:30GLOBEPassage Bio Announces Inducement Grant Under Nasdaq Listing..
13/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:00EDGAR2Form 8-K - Current report
13/11/202323:00GLOBEPassage Bio Reports Third Quarter 2023 Financial Results and..
30/10/202322:00GLOBEPassage Bio to Present at Guggenheim’s 5th Annual..
21/10/202307:30GLOBEPassage Bio Announces Inducement Grants Under Nasdaq Listing..
25/9/202321:00GLOBEPassage Bio to Present at Chardan’s 7th Annual Genetic..
02/9/202306:10EDGAR2Form 8-K - Current report
07/8/202321:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202321:15GLOBEPassage Bio Reports Second Quarter 2023 Financial Results..
07/8/202321:15EDGAR2Form 8-K - Current report
07/8/202321:00GLOBEPassage Bio Announces Promising Interim Clinical Data from..
02/8/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202321:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
01/8/202307:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202307:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/7/202321:00GLOBEPassage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of..
29/7/202308:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202321:00EDGAR2Form 8-K - Current report
05/6/202321:00GLOBEPassage Bio to Present at Goldman Sachs 44th Annual Global..
11/5/202321:00GLOBEPassage Bio Reports First Quarter 2023 Financial Results and..
04/5/202321:00GLOBEPassage Bio Announces Recipient of Second Annual Tachi..

Your Recent History

Delayed Upgrade Clock